Bard Geesaman
InvestorManaging Partner at MPM BioImpact
Deals · 2
Rekindle TherapeuticsBoard seat
via MPM BioImpact · filed Nov 2018 · $6.5M raise
Maverick TherapeuticsBoard seat
via MPM BioImpact · filed Jan 2017 · $56M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at MPM BioImpact
Alim Ladha
Senior Associate at MPM Capital
Andrew Scharenberg
Entrepreneur Partner at MPM BioImpact
Ansbert Gadicke, M.D.
Chairman at MPM BioImpact
Ansbert K. Gadicke
Managing Partner at MPM BioImpact
Aparna Parikh
Entrepreneur Partner at MPM BioImpact
Binsen Li
Principal at MPM BioImpact
Brendan Furey
Chief Compliance Officer at MPM BioImpact
Brian Goodman
Partner at MPM BioImpact
Network10
Alim Ladha
Senior Associate at MPM Capital
Briggs Morrison
Entrepreneur Partner at MPM BioImpact
Dan Hicklin
Managing Partner at MPM Capital
David Kolesky
Principal at MPM BioImpact
David Stack
Managing Partner at MPM Capital
Detlev Biniszkiewicz
Managing Director at MPM BioImpact
Devin Quinlan
Principal at MPM BioImpact
Ed Hurwitz
Managing Director at MPM Capital
Elizabeth Stoner
Entrepreneur Partner at MPM BioImpact
Geraldine Paulus
Senior Associate at MPM Capital
Investors connected to Bard in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Bard Geesaman work?
- Bard Geesaman is Managing Partner at MPM BioImpact.
- What companies did Bard Geesaman found?
- Bard Geesaman founded Chiasma, Maverick Therapeutics, Rekindle Therapeutics.










